False ozmpic found in the American drug supply chain

Among the growing demand for GLP-1 drugs used to treat diabetes and weight loss support, the American Food and Drug Agency (FDA) has issued a urgent warning for consumers with OZEMPIC. The agency calls users for thorough control of drug label after discovering that hundreds of counterfeit injections Ozmpic have introduced circulation outside the authorized supply chain in the USA.

Alert FDA after confirming Novo Nordisk, a manufacturer of Ozmpic and a drug for slimming Wegova, which forged pens ozempic 1 milligram infiltrated the American market. In response, FDA won the identified false products on April 9, 2025.

“The agency advises wholesalers, retail pharmacies, healthcare doctors and patients to check the product received, not distribution, use or sell products marked behind the NAR0074 number and serial number 430834149057, as in the photo below. Some forged products can still be available for purchase,” said FDA WAWA press releasewhich included images of counterfeit labels for information purposes.

In an update issued on Monday, the agency continued to warn it in alert for additional suspicious packaging, in particular “parties marked by PAR0362 and serial numbers, starting from the first eight digits 51746517”.

Six undesirable events related to the affected plot have already been reported, although none of them seems to be directly caused by the counterfeit product itself. All six incidents were reported by Novo Nordisk, a drug manufacturer, as part of continuous monitoring.

The FDA emphasized its commitment to combating counterfeit medications, stating that “is seriously approaching possible counterfeit products.” The agency works closely with Novo Nordisk in order to “identify, examine and remove further suspicious counterfeit products for semaglutide injection found in the US” as part of the ongoing investigation.

Meanwhile, healthcare employees and consumers are asked to report any side effects or adverse reactions related to ozempiccia through information about medwatch and the program for reporting undesirable events. Reports can be sent online or by faxing a completed form to 1-800-FDA-0178. In addition, anyone who suspects counterfeit or manipulated medicines, especially online sellers, should contact the local Corporate Coordinator of FDA’s consumer complaints or report activities directly through the FDA criminal portal.